Antihypertensive scripts flout guidelines

Many patients needing antihypertensive therapy are being put straight onto fixed-dose combination products contrary to guidelines, an Australian study finds.

Analysis of data from the Department of Veterans’ Affairs found fewer than 1% of patients taking a fixed-dose combination were first stabilised on the two individual components, as recommended in guidelines from the Heart Foundation and the NPS.

A review of pharmacy claims data from 300,000 veterans and dependants found that 58% of patients